Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

The global spinal cord stimulators market is on a robust growth trajectory, poised to reach an impressive valuation of USD 5,441.4 million by 2033. Currently valued at USD 2,702.7 million in 2023, the ...

Spinal cord ... 27.5% from Medtronic, 22.5% from Nevro, 11.8% from Abbott, and 1.3% from Saluda. Among 47 patients implanted with Abbott devices, 34% received a system for DRG stimulation.

Spinal cord and dorsal root ganglion stimulation ... In this group, 37% of patients received devices from Boston Scientific, 27.5% from Medtronic, 22.5% from Nevro, 11.8% from Abbott, and 1.3% from ...

Spinal cord compression—also called cervical spondylotic myelopathy (CSM)— is caused by any condition that puts pressure on the spinal cord. Symptoms may develop suddenly or gradually and may include ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

Spinal meningitis is the inflammation of tissues, called the meninges, that surround and protect the brain and spinal cord. It usually stems from an infection, leading to symptoms such as a stiff neck ...

Bourguignon, Lukas et al. systematically review the effect of drugs commonly administered after traumatic spinal cord injury on the neurological recovery in both animal studies and humans.

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.